MedTrace Logo

Comparison Of Dexmedetomidine, Fentanyl And Lignocaine In Attenuation Of Hemodynamic Response To Direct Laryngoscopy And Intubation In Patient Undergoing Laparoscopic Cholecystectomy

NCT04138472 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2020-02-07

No results posted yet for this study

Summary

Comparison Of Dexmedetomidine, Fentanyl And Lignocaine In Attenuation Of Hemodynamic Response To Direct Laryngoscopy And Intubation In Patient Undergoing Laparoscopic Cholecystectomy

Conditions

  • Laparoscopic Cholecystectomy

Interventions

DRUG

dexmedetomidine

intravenous dexmedetomidine 0.06mg/kg in 100ml normal saline 0.9% over 10minutes.

DRUG

fentanyl

intravenous fentanyl at 2mcg/kg in 100ml saline over 10 minutes in induction room.

DRUG

lidocaine

intravenous lidocaine 1.5mg/kg in 100ml saline over 10 minutes in induction room.

Sponsors & Collaborators

  • Dow University of Health Sciences

    collaborator OTHER

  • Sana Urooj

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-30
Primary Completion
2020-02-29
Completion
2020-02-29

Countries

  • Pakistan

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04138472 on ClinicalTrials.gov